CrossrefInfokarte
The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome
Gastroenterology Review · 2022 · 17 (1) · 28-34
DOI: 10.5114/pg.2021.112681 ↗Abstract
Kein Abstract verfügbar.
EUVIMED